Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies
Clinical trial NCT04475523 · COMPLETED
Trial details
- NCT number
- NCT04475523
- Sponsor
- Curis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2023-05-19
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.